HCPCS code A9576: ProHance injection, per 1 mL2026 Medicare rate & RVUs

Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.

What A9576 covers

A9576 identifies ProHance, an intravenous gadoteridol contrast agent used to enhance MRI images, particularly for imaging the brain, spine, and surrounding central nervous system tissues. Radiology practices and imaging facilities report the drug when they furnish it for an MRI. The multipack designation identifies the product presentation, while the HCPCS unit is based on volume administered.

Medicare assigns A9576 statutory-exclusion status X: it is not paid under the physician fee schedule because it is not a physician service under the Medicare statute. When covered, it is treated as a Part B drug and is generally paid using CMS’s quarterly Average Sales Price drug pricing files; the Medicare contractor determines coverage. Report one unit for each 1 mL of gadoteridol administered, supported by the medication record.

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

Where A9576 pays more and less

The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.

109 of 109 payment localities

A9576 rates by state

Office rate range in each state. Select a state to see its payment localities.

How the A9576 rate is calculated

Each of A9576’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.

Payment rules and modifiers for A9576

A9576 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.

A9576 compared with similar codes

How to choose

A9578MultiHance injectionMultipack, per mL

A9578 identifies MultiHance multipack, while A9576 identifies ProHance multipack. Select according to the contrast agent administered.

A9577MultiHance injectionPer mL

A9577 identifies MultiHance rather than ProHance. The drug furnished, not the MRI body site, distinguishes these codes.

A9579MRI contrast agentUnspecified agent, per mL

A9579 is for a gadolinium-based MRI contrast agent when no more specific agent code is used; A9576 identifies gadoteridol specifically.

A9585Gadobutrol injectionPer 0.1 mL

A9585 identifies gadobutrol. A9576 applies when the administered agent is gadoteridol.

Codes related to A9576

Related codes aren’t interchangeable: bill the code that matches the service performed.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.

CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027

Open CMS sourceHow we calculate rates